Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting*
Authors:
- Alasdair McKeownAMAlasdair McKeown
- Bernard L. CroalBCBernard L. Croal
- William J. MutchWMWilliam J. Mutch
- Graham S. HillisGHGraham S. Hillis
- 1 February 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 33 (2) , 437-442
Abstract
To determine whether preoperative plasma levels of B-type natriuretic peptide would allow for the prediction of perioperative and early postoperative cardiovascular support requirements and hospital bed usage after coronary artery surgery. A prospective observational cohort study. A tertiary referral cardiothoracic unit in Scotland. Forty-six consecutive patients undergoing coronary artery surgery. None. Demographics, clinical details, preoperative and postoperative B-type natriuretic peptide levels, type of surgery, postoperative complications, postoperative cardiac troponin I levels, and duration of stay were collected. Preoperative plasma levels of B-type natriuretic peptide are significantly higher in patients who require perioperative inotropic or mechanical cardiovascular support, compared with those who do not. They are also higher in those who require postoperative inotropic or mechanical cardiovascular support, compared with those who do not. B-type natriuretic peptide levels are higher in those who require increased intensive care unit stay but not a prolonged hospital stay. Preoperative plasma levels of B-type natriuretic peptide levels may be useful in predicting the need for increased peri and postoperative cardiovascular support and a more prolonged stays in intensive care following coronary artery surgery.Keywords
This publication has 16 references indexed in Scilit:
- Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure: A Multisite StudyClinical Chemistry, 2004
- Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockersJACC, 2004
- A-Type and B-Type Natriuretic Peptides in Cardiac Surgical ProceduresAnesthesia & Analgesia, 2004
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- European system for cardiac operative risk evaluation (EuroSCORE)European Journal of Cardio-Thoracic Surgery, 1999
- Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patientsEuropean Journal of Cardio-Thoracic Surgery, 1999
- Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgeryCritical Care Medicine, 1998
- Clinical Applications of Risk-Assessment Protocols in the Management of Individual PatientsThe Annals of Thoracic Surgery, 1997
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Relationship between Plasma Level of Brain Natriuretic Peptide and Myocardial Infarct SizeCardiology, 1994